BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21316841)

  • 1. Pentamidine reduces expression of hypoxia-inducible factor-1α in DU145 and MDA-MB-231 cancer cells.
    Jung HJ; Suh SI; Suh MH; Baek WK; Park JW
    Cancer Lett; 2011 Apr; 303(1):39-46. PubMed ID: 21316841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silibinin inhibits expression of HIF-1alpha through suppression of protein translation in prostate cancer cells.
    Jung HJ; Park JW; Lee JS; Lee SR; Jang BC; Suh SI; Suh MH; Baek WK
    Biochem Biophys Res Commun; 2009 Dec; 390(1):71-6. PubMed ID: 19778521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-glucosamine down-regulates HIF-1alpha through inhibition of protein translation in DU145 prostate cancer cells.
    Park JY; Park JW; Suh SI; Baek WK
    Biochem Biophys Res Commun; 2009 Apr; 382(1):96-101. PubMed ID: 19254699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
    Hiraga T; Kizaka-Kondoh S; Hirota K; Hiraoka M; Yoneda T
    Cancer Res; 2007 May; 67(9):4157-63. PubMed ID: 17483326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha).
    Anastasiadis AG; Ghafar MA; Salomon L; Vacherot F; Benedit P; Chen MW; Shabsigh A; Burchardt M; Chopin DK; Shabsigh R; Buttyan R
    J Cancer Res Clin Oncol; 2002 Jul; 128(7):358-62. PubMed ID: 12136249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin down-regulates HIF-1 alpha expression through inhibition of protein translation in prostate cancer cells.
    Park JW; Hwang MS; Suh SI; Baek WK
    J Pineal Res; 2009 May; 46(4):415-21. PubMed ID: 19552765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells.
    Mirzoeva S; Kim ND; Chiu K; Franzen CA; Bergan RC; Pelling JC
    Mol Carcinog; 2008 Sep; 47(9):686-700. PubMed ID: 18240292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
    Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
    Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer.
    Zhong H; Agani F; Baccala AA; Laughner E; Rioseco-Camacho N; Isaacs WB; Simons JW; Semenza GL
    Cancer Res; 1998 Dec; 58(23):5280-4. PubMed ID: 9850048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor-1alpha induces the epithelial-mesenchymal transition of human prostatecancer cells.
    Luo Y; He DL; Ning L; Shen SL; Li L; Li X
    Chin Med J (Engl); 2006 May; 119(9):713-8. PubMed ID: 16701010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bafilomycin induces the p21-mediated growth inhibition of cancer cells under hypoxic conditions by expressing hypoxia-inducible factor-1alpha.
    Lim JH; Park JW; Kim MS; Park SK; Johnson RS; Chun YS
    Mol Pharmacol; 2006 Dec; 70(6):1856-65. PubMed ID: 16940187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-dependent leptin expression in breast cancer cells.
    Bartella V; Cascio S; Fiorio E; Auriemma A; Russo A; Surmacz E
    Cancer Res; 2008 Jun; 68(12):4919-27. PubMed ID: 18559540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigallocatechin gallate inhibits HIF-1alpha degradation in prostate cancer cells.
    Thomas R; Kim MH
    Biochem Biophys Res Commun; 2005 Aug; 334(2):543-8. PubMed ID: 16005427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
    Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
    Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-inducible factor-1 in human breast and prostate cancer.
    Kimbro KS; Simons JW
    Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect and mechanism of apigenin on VEGF expression in human breast cancer cells].
    Jin XY; Ren CS
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):495-9. PubMed ID: 18069627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Over-expression of hypoxia-inducible factor-1 alpha increases angiogenesis of LNCaP cells].
    Han YL; He DL; Luo Y; Cheng HP; Zhu GF
    Zhonghua Nan Ke Xue; 2007 Nov; 13(11):988-91. PubMed ID: 18077909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
    García-Maceira P; Mateo J
    Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.
    Menendez JA; Vellon L; Oza BP; Lupu R
    J Cell Biochem; 2005 Apr; 94(5):857-63. PubMed ID: 15669079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manganese superoxide dismutase suppresses hypoxic induction of hypoxia-inducible factor-1alpha and vascular endothelial growth factor.
    Wang M; Kirk JS; Venkataraman S; Domann FE; Zhang HJ; Schafer FQ; Flanagan SW; Weydert CJ; Spitz DR; Buettner GR; Oberley LW
    Oncogene; 2005 Dec; 24(55):8154-66. PubMed ID: 16170370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.